SCHEMBL7366879

SCHEMBL7366879

O=[N+]([O-])c1cc(-c2cnc3ccccc3n2)cc(O)c1O

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.63
NPC1 O15118 7/20 0.57
RAB9A P51151 5/20 0.57
ALDH1A1 P00352 5/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
LMNA P02545 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HTT P42858 2/20 0.54
GAA P10253 1/20 0.53
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
BCHE P06276 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374010 0.84 MAPT (0.66) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7371486 0.83 SMN1; SMN2 (0.47) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
Bromide SCHEMBL7369009 0.77 CRHBP (0.54) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL27844117 0.75 MAPT (0.60) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
Bromide SCHEMBL7368418 0.73 MAPT (0.47) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL8726189 0.73 MAPT (0.53) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7367829 0.73 MAPT (0.53) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL27844118 0.73 MAPT (0.62) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7153742 0.73 NPC1 (1.00) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7373629 0.73 MMP2 (0.58) MAPTNPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed